| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Amyris, Inc. > News item |
Amyris closes sale of MenoLabs assets to Dr. Reddy’s Laboratories
By Sarah Lizee
Olympia, Wash., Jan. 3 – Amyris, Inc. closed the sale of its MenoLabs brand assets to Dr. Reddy’s Laboratories, Inc. for $3 million on Friday, according to a notice filed with the U.S. Bankruptcy Court for the District of Delaware.
As previously reported, Amyris received court approval for four asset sales, including its Biossance brand assets to THG Beauty USA, LLC for $20 million, its 4U brand assets to Scent Theory Products, LLC for $600,000, and its Pipette brand assets to HRB Brands, LLC for $1.75 million, in addition to the MenoLabs assets.
Intrepid Investment Bankers LLC acted as investment banker.
Emeryville, Calif.-based Amyris is a synthetic biotechnology company. The company filed bankruptcy on Aug. 9 under Chapter 11 case number 23-11131.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.